These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26825144)
1. Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid. Saglam O; Bahsi R; Akkoca Y; Filik L Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):360-1. PubMed ID: 26825144 [No Abstract] [Full Text] [Related]
2. Remission of drug-induced hepatitis after switching from risperidone to paliperidone. Paulzen M; Orfanos S; Gründer G Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492 [No Abstract] [Full Text] [Related]
3. Switching between clozapine and risperidone treatment. Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773 [No Abstract] [Full Text] [Related]
4. Rapid onset of risperidone-induced hepatotoxicity. Phillips EJ; Liu BA; Knowles SR Ann Pharmacother; 1998; 32(7-8):843. PubMed ID: 9681106 [No Abstract] [Full Text] [Related]
8. Is liver function monitoring warranted during risperidone treatment? Landau J; Martin A J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1007-8. PubMed ID: 9785708 [No Abstract] [Full Text] [Related]
9. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. Smelson DA; Roy A; Roy M Can J Psychiatry; 1997 May; 42(4):431. PubMed ID: 9161774 [No Abstract] [Full Text] [Related]
10. Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature. Khorassani F; Sousonis F; Lopez LV Am J Health Syst Pharm; 2020 Sep; 77(19):1578-1584. PubMed ID: 32699878 [TBL] [Abstract][Full Text] [Related]
14. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine. Mendhekar DN; Inamdar A J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136 [No Abstract] [Full Text] [Related]
15. Withdrawal-emergent dyskinesia in a patient taking risperidone/citalopram. Miller LJ Ann Pharmacother; 2000 Feb; 34(2):269. PubMed ID: 10676841 [No Abstract] [Full Text] [Related]
16. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient. Hou YC; Lai CH J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786 [No Abstract] [Full Text] [Related]
17. Acute agranulocytosis when switching from risperidone to paliperidone. Wakuda T; Suzuki A; Hasegawa M; Ichikawa D; Yamasue H Aust N Z J Psychiatry; 2019 Jun; 53(6):586-587. PubMed ID: 30636434 [No Abstract] [Full Text] [Related]
18. Persistent hiccups associated with switching from paliperidone to amisulpride. Cheng CM; Tsai SJ Psychiatry Clin Neurosci; 2015 Jun; 69(6):383. PubMed ID: 25210776 [No Abstract] [Full Text] [Related]
19. Tics with risperidone withdrawal. Rowan AB; Malone RP J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):162-3. PubMed ID: 9031567 [No Abstract] [Full Text] [Related]
20. Hepatotoxicity to Risperidone. André RT; Romão JP; Rebelo MS; Pais FC; Fernandes AM; Baronet PM; Abreu MN Prim Care Companion CNS Disord; 2024 Mar; 26(2):. PubMed ID: 38579255 [No Abstract] [Full Text] [Related] [Next] [New Search]